Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Cohen Fred E
Relationship:  
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   366,218    

Indirect Shares

   4,593,263      
Direct Value   $5,073,150    

Indirect Value

   $66,313,019      
Total Shares   4,959,481      
Total Value   $71,386,168      


Five Prime Therapeutics Inc $942,666 Biocryst Pharmaceuticals Inc $810,794 Caredx, Inc. $1,934,517 Intellia Therapeutics, Inc. $963,222 Urogen Pharma Ltd. $203,850 Veracyte, Inc. $218,100 Progyny, Inc. $0 Five Prime Therapeutics Inc $942,666 Biocryst Pharmaceuticals Inc $810,794 Caredx, Inc. $1,934,517 Intellia Therapeutics, Inc. $963,222 Urogen Pharma Ltd. $203,850 Veracyte, Inc. $218,100 Progyny, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   1.0   
     Percentage Gain/Loss :
     0.0%
 216.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genomic Health Inc GHDX Director 2019-11-08 0 2019-11-08 0    Premium*  
            Five Prime Therapeutics Inc FPRX Director 2016-01-11 24,807 2014-07-01 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2017-09-18 119,410 2014-08-29 0    Premium*  
            Caredx, Inc. CDNA Director 2023-06-16 132,592 2014-10-01 0    Premium*  
            Intellia Therapeutics, Inc. NTLA Director 2023-06-14 41,716 2019-03-01 0    Premium*  
            Urogen Pharma Ltd. URGN Director 2019-02-06 15,000 2023-07-26 69,339    Premium*  
            Veracyte, Inc. VCYT Director 2020-10-19 10,000 2019-08-02 0    Premium*  
            Progyny, Inc. PGNY Director 2024-05-23 22,693 2020-10-24 0    Premium*  
            Kyverna Therapeutics KYTX 2024-02-12 0 2024-02-12 4,523,924    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •      –    2013-04-01 4 A $27.99 $9,992 D/D 357 60,314 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-01-01 4 A $29.39 $9,993 D/D 340 65,578 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-07-01 4 A $32.55 $9,993 D/D 307 66,202 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2016-12-01 4 A $5.59 $9,995 D/D 1,788 115,867 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2017-03-01 4 A $6.24 $9,996 D/D 1,602 117,469 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2017-06-01 4 A $5.15 $9,996 D/D 1,941 119,410 0 -
GHDX Genomic Health Inc Director   –       •      –    2013-01-01 4 A $27.24 $9,997 D/D 367 59,957 0 -
GHDX Genomic Health Inc Director   –       •      –    2016-01-01 4 A $35.20 $9,997 D/D 284 64,128 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2016-09-01 4 A $4.11 $10,000 D/D 2,433 114,079 0 -
GHDX Genomic Health Inc Director   –       •      –    2012-10-01 4 A $35.89 $10,336 D/D 288 59,590 0 -
GHDX Genomic Health Inc Director   –       •      –    2019-10-01 4 A $67.28 $12,447 D/D 185 69,120 0 -
GHDX Genomic Health Inc Director   –       •      –    2019-07-01 4 A $58.86 $12,478 D/D 212 68,935 0 -
CDNA Caredx, Inc. Director   –       •      –    2018-08-28 4 OE $1.22 $18,300 D/D 15,000 52,901 0 -
VCYT Veracyte, Inc. Director   •       •      –    2020-10-19 4 OE $7.60 $76,000 D/D 10,000 10,000 0 -
CDNA Caredx, Inc. Director   –       •      –    2020-09-21 4 OE $4.95 $84,905 D/D 16,424 90,893 0 -
GHDX Genomic Health Inc Director   –       •      –    2012-08-01 4 OE $10.73 $88,523 D/D 8,250 59,302 0 -
CDNA Caredx, Inc. Director   –       •      –    2019-07-11 4 OE $5.02 $109,672 D/D 15,765 71,279 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-05-19 4 OE $14.37 $118,553 D/D 8,250 74,145 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2015-01-08 4 OE $1.29 $129,000 D/D 100,000 101,457 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-05-16 4 OE $18.13 $149,573 D/D 8,250 74,145 0 -
NTLA Intellia Therapeutics, In... Director   –       •      –    2019-03-01 4 A $16.89 $168,936 D/D 10,000 10,000 0 -
GHDX Genomic Health Inc Director   –       •      –    2018-08-07 4 OE $25.79 $212,768 D/D 8,250 75,572 0 -
CDNA Caredx, Inc. Director   –       •      –    2021-01-06 4 OE $14.74 $221,100 D/D 15,000 105,893 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2017-09-18 4 OE $4.27 $231,648 D/D 54,250 173,660 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-05-19 4 S $29.54 $243,745 D/D (8,250) 65,895 0 -
  117  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us